Clinical Outcomes in Patients with Parkinson's Disease Treated with a Monoamine Oxidase Type‐B inhibitor: A Cross‐Sectional, Cohort Study

ConclusionLong‐term use of MAOB‐I therapy was associated with reduced risk of dyskinesia in patients with PD.

Source: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - July 3, 2015 Category: Drugs & Pharmacology Authors: Khashayar Dashtipour, Jack J. Chen, Camellia Kani, Khaled Bahjri, Mark Ghamsary Tags: Original Research Article Source Type: research